Treatment with human chorionic gonadotropin for PADAM: A preliminary report

Aging Male

Volumn 8, Issue 3-4, 2005, Pages 175-179

  Tsujimura, A ^a   Matsumiya, K ^a   Takao, T ^a   Miyagawa, Y ^a   Takada, S ^a   Koga, M ^b   Iwasa, A ^c   Takeyama, M ^b   Okuyama, A ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Central Hospital   (Japan)

^c Iwasa Clinic   (Japan)

Author keywords

Aging Males' Symptoms scale; Human chorionic gonadotropin; Partial androgen deficiency of the aging male

Indexed keywords

CHORIONIC GONADOTROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; ERYTHROCYTE COUNT; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LABORATORY TEST; MALE; PARTIAL ANDROGEN DEFICIENCY OF THE AGING MALE; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF CONCEPT; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

AGED; AGING; ANDROGENS; BIOLOGICAL AVAILABILITY; CHORIONIC GONADOTROPIN; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; QUESTIONNAIRES; SAFETY; TESTOSTERONE; TREATMENT OUTCOME;

EID: 30344455295     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530500282794     Document Type: Article

References (37)

1. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74-86.
2. Morley JE. Androgens and aging. Maturitas 2001;38:61-71.
3. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman J-M, Tan HM, Torres LO. Endocrine aspects of sexual dysfunction in men. J Sex Med 2004;1:69-81.
4. Morley JE, Perry HM III. Androgen deficiency in aging men. Med Clin North Am 1999;83:1279-1289.
5. Vermeulen A. Andropause. Maturitas 2000;34:5-15.
6. Morales A, Heaton JP, Carson CC III. Andropause: a misnomer for a true clinical entity. J Urol 2000;163:705-712.
7. Morley JE. Testosterone replacement and the physiologic aspects of aging in men. Mayo Clin Proc 2000;75(Suppl):S83-S87.
8. Morley JE. Testosterone replacement in older men and women. J Gend Specif Med 2001;4:49-53.
9. Morley JE, Perry HM III. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003;85:367-373.
10. Comhaire FH. Andropause: hormone replacement therapy in the ageing male. Eur Urol 2000;38:655-662.
11. Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997;157:849-854.
12. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999;84:3469-3478.
13. Veldhuis JD, Iranmanesh A, Godschalk M, Mulligan T. Older men manifest multifold synchrony disruption of reproductive neurohormone outflow. J Clin Endocrinol Metab 2000;85:1477-1486.
14. Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992;75:707-713.
15. Veldhuis JD, Zwart A, Mulligan T, Iranmanesh A. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men. J Clin Endocrinol Metab 2001;86:529-535.
16. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651-655.
17. Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002;17:625-633.
18. Amelar RD, Dubin L. Human chorionic gonadotrophin therapy in male infertility. JAMA 1977;237:2423.
19. Schill WB, Jungst D, Unterburger P, Braun S. Combined hMG/hCG treatment in subfertile men with idiopathic normogonadotrophic oligozoospermia. Int J Androl 1982;5:467-477.
20. Heinemann LA, Zimmermann T, Vermeulen A, Thiel C. A new 'aging males' symptoms' (AMS) rating scale. Aging Male 1999;2:105-114.
21. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
22. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965;13:508-515.
23. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647-2653.
24. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999;84:1966-1972.
25. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002;282:E601-E607.
26. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000;57:141-147; discussion 155-156.
27. Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997;82:3793-3796.
28. Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab 2002;87:1467-1472.
29. Morley JE, Tariq SH. Sexuality and disease. Clin Geriatr Med 2003;19:563-573.
30. Namiki M, Kitamura M, Miyake O, Nakamura M, Okuyama A, Sonoda T, Takeyama M, Fujioka H, Matsumoto K. Reduction of testicular human chorionic gonadotropin receptors by human chorionic gonadotropin in infertile men. Arch Androl 1988;20:45-50.
31. Tsujimura A, Matsumiya K, Matsuoka Y, Takahashi T, Koga M, Iwasa A, Takeyama M, Okuyama A. Bioavailable testosterone with age and erectile dysfunction. J Urol 2003;170:2345-2347.
32. Graziottin A. Libido: the biologic scenario. Maturitas 2000;34(Suppl 1):S9-S16.
33. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092-1098.
34. Liu PY, Wishart SM, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 2002;87:3125-3135.
35. T'Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004; 29: 201-214.
36. T'Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM. Self-referred patients in an aging male clinic: much more than androgen deficiency alone. Aging Male 2003;6:157-165.
37. Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, Koga M, Iwasa A, Takeyama M, Okuyama A. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Imp Res 2005; 17:259-263.